Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
8.16
-0.46 (-5.34%)
Mar 31, 2025, 10:47 AM EDT - Market open
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 22, with a low estimate of 15 and a high estimate of 36. The average target predicts an increase of 169.61% from the current stock price of 8.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +169.61% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +169.61% | Mar 5, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +218.63% | Feb 25, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $22 | Buy | Maintains | $19 → $22 | +169.61% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +169.61% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
69.99M
from 108.30M
Decreased by -35.38%
Revenue Next Year
93.28M
from 69.99M
Increased by 33.28%
EPS This Year
-0.99
from -0.70
EPS Next Year
-0.98
from -0.99
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 107.1M | 213.2M | 321.4M | ||
| Avg | 70.0M | 93.3M | 156.6M | ||
| Low | 33.9M | n/a | 32.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.1% | 204.7% | 244.6% | ||
| Avg | -35.4% | 33.3% | 67.8% | ||
| Low | -68.7% | - | -65.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.67 | -0.64 | 0.26 | ||
| Avg | -0.99 | -0.98 | -0.54 | ||
| Low | -1.30 | -1.41 | -1.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.